Europe: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

Featured Journal Content

 

Europe: COVID-19 Vaccines – Announcements/Regulatory Actions/Deployment

 

European Medicines Agency
News & Press Releases
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 January 2022 (new)
CHMP, Last updated: 28/01/2022

 

News: COVID-19: EMA recommends conditional marketing authorisation for Paxlovid (updated)
CHMP, PRAC, Last updated: 28/01/2022
EMA’s human medicines committee (CHMP) has recommended granting a conditional marketing authorisation for the oral antiviral medicine Paxlovid (PF-07321332 / ritonavir) for the treatment of COVID-19. The applicant is Pfizer Europe MA EEIG…

 

News: Regulatory harmonisation of clinical trials in the EU: Clinical Trials Regulation to enter into application and new Clinical Trials Information System to be launched (new)
Last updated: 25/01/2022

 

News: Increase in manufacturing capacity for Vaxzevria (previously COVID-19 Vaccine AstraZeneca) (new)
CHMP, Last updated: 24/01/2022

 

::::::

European Centre for Disease Prevention and Control
https://www.ecdc.europa.eu/en
Latest Updates
Publication
Guidance on ending the isolation period for people with COVID-19, third update
Technical report – 28 Jan 2022

Publication
Communicable disease threats report, 23-29 January 2022, week 4
Publication – 28 Jan 2022

News
Societal pressure from unprecedented Omicron spread can be eased through increased vaccination uptake
Press release – 27 Jan 2022

Publication
Assessment of the further spread and potential impact of the SARS-CoV-2 Omicron variant of concern in the EU/EEA, 19th update
Risk assessment – 27 Jan 2022

News
Strengthening COVID-19 information and vaccination caravans in rural communities from Romania
News – 27 Jan 2022

 

::::::

Accessed 29 Jan 2022
https://vaccinetracker.ecdc.europa.eu/public/extensions/COVID-19/vaccine-tracker.html#uptake-tab

 

::::::

European Commission
https://ec.europa.eu/commission/presscorner/home/en
Statement 28 January 2022
European Health Union: new rules to improve clinical trials in the EU
As of Monday 31 January,  the assessment and supervision of clinical trials throughout the EU will be harmonised, notably via a Clinical Trials Information System (CTIS) run by the European Medicines Agency.
[See Milestones above for detail]

Press release 25 January 2022
European Health Union: a stronger role for the European Medicines Agency
Today, as part of the on-going work to build a strong European Health Union, the Council has adopted the Regulation revising the mandate of the European Medicines Agency (EMA).
[See Milestones above for detail]